Hrt Financial LP Aptinyx Inc. Transaction History

Hrt Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.35 - $0.72 $4,579 - $9,419	13,083 New	13,083 $4,000
Q4 2021 Feb 14, 2022	SELL	$2.11 - $3.0 $146,241 - $207,927	-69,309 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.21 - $2.89 $46,659 - $61,016	-21,113 Reduced 23.35%	69,309 $162,000
Q2 2021 Aug 16, 2021	BUY	$2.39 - $3.5 $216,108 - $316,477	90,422 New	90,422 $255,000
Q3 2020 Nov 13, 2020	SELL	$3.05 - $4.99 $102,849 - $168,267	-33,721 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.99 - $4.4 $67,104 - $148,372	33,721 New	33,721 $140,000
Q1 2020 May 15, 2020	SELL	$1.81 - $5.03 $40,075 - $111,369	-22,141 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.84 - $4.25 $62,880 - $94,099	22,141 New	22,141 $75,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.